Literature DB >> 11422009

Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.

A Fourrier, B Bégaud, A Alpérovitch, M H Verdier-Taillefer, E Touzé, N Decker, J L Imbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11422009      PMCID： PMC2014467          DOI： 10.1046/j.1365-2125.2001.01364.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

Review 1.  Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview.

Authors:  G Rosati
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

Review 2.  [Epidemiology of multiple sclerosis].

Authors:  N Delasnerie-Lauprêtre; A Alpérovitch
Journal:  Rev Prat       Date:  1991-09-15
  2 in total
  7 in total

1.  Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study.

Authors:  Véronique Pizzoglio; Ismaïl Ahmed; Pascal Auriche; Pascale Tuber-Bitter; Françoise Haramburu; Carmen Kreft-Jaïs; Ghada Miremont-Salamé
Journal:  Eur J Clin Pharmacol       Date:  2011-12-06       Impact factor: 2.953

2.  Authors' Reply to Cohen et al.'s Comment on "Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database".

Authors:  Julie Mouchet; Bernard Bégaud
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

3.  Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.

Authors:  Hélène Théophile; Nicholas Moore; Philip Robinson; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

Review 4.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

5.  Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database.

Authors:  Julie Mouchet; Bernard Bégaud
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.228

6.  Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Authors:  Dominique Le Houézec
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

7.  Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases.

Authors:  Fanny Leroy; Jean-Yves Dauxois; Hélène Théophile; Françoise Haramburu; Pascale Tubert-Bitter
Journal:  BMC Med Res Methodol       Date:  2014-02-03       Impact factor: 4.615
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.